Personal Information
Entreprise/Lieu de travail
New York, NY United States
Profession
CEO
Secteur d’activité
Finance / Banking / Insurance
Site Web
about.me/thompson.dean
À propos
As the CEO of Avista Capital Partners, Thompson Dean is responsible for working with his team as they ensure their middle market portfolio companies exploit their growth potential. Some of the industries the company focuses on include healthcare and communications. The overall goal is making sound investments and implementing and supporting management teams that will naturally lend themselves to the organic growth of the assets controlled. Before he started Avista, Thompson Dean led as a managing partner for DLJ Merchant Banking Partners for ten years. Mr. Dean began his educational career at the University of Virginia, where he earned his BA in economics and foreign affairs.
Mots-clés
thompson dean
avista
karo pharma
trimb acquisition
avista portfolio
osmotica pharmaceuticals
weight training
joe matejka
organogenesis
avista healthcare public acquisition corp.
leveraged buyouts
successful collaboration
avista fund
ongoing success
nasal therapy
fda
optinose
Tout plus
Présentations
(4)Personal Information
Entreprise/Lieu de travail
New York, NY United States
Profession
CEO
Secteur d’activité
Finance / Banking / Insurance
Site Web
about.me/thompson.dean
À propos
As the CEO of Avista Capital Partners, Thompson Dean is responsible for working with his team as they ensure their middle market portfolio companies exploit their growth potential. Some of the industries the company focuses on include healthcare and communications. The overall goal is making sound investments and implementing and supporting management teams that will naturally lend themselves to the organic growth of the assets controlled. Before he started Avista, Thompson Dean led as a managing partner for DLJ Merchant Banking Partners for ten years. Mr. Dean began his educational career at the University of Virginia, where he earned his BA in economics and foreign affairs.
Mots-clés
thompson dean
avista
karo pharma
trimb acquisition
avista portfolio
osmotica pharmaceuticals
weight training
joe matejka
organogenesis
avista healthcare public acquisition corp.
leveraged buyouts
successful collaboration
avista fund
ongoing success
nasal therapy
fda
optinose
Tout plus